The Global Automated Cell Culture Systems Industry is on an impressive trajectory, with an astounding Compound Annual Growth Rate (CAGR) of 8.4%. According to recent projections, this market is set to skyrocket from its 2022 valuation of US$ 10.91 Billion to an estimated US$ 20.87 Billion by 2030. Besides, 3D cell cultures, which were cumbersome …
Tag Archives: Automated Cell Culture Systems Market
Global Automated Cell Culture Systems Industry is expected to reach a valuation of US$ 20.87 Billion by 2030, with a CAGR of 8.4%
In a remarkable surge, the Global Automated Cell Culture Systems Industry is expected to achieve unprecedented growth at an impressive Compound Annual Growth Rate (CAGR) of 8.4%. This market, which was valued at US$ 10.91 Billion in 2022, is poised to scale new heights and reach a valuation of US$ 20.87 Billion by 2030. Automated …
Revolutionizing Cell Culture: Automated Systems to Reach US$ 20.87 Billion by 2030 with an Impressive 8.4% CAGR | Reveal by FMI
The global Automated Cell Culture Systems Market is expected to grow at an 8.4% CAGR from US$ 10.91 billion in 2022 to US$ 20.87 billion by 2030. .High-throughput screening technology has turned out to be the need of the hour, especially with a large number of biological/chemical compounds being tested to target a particular ailment. …
Automated Cell Culture Systems Market New Innovations, Research and Growth Factor till 2028
According to Future Market Insights, the Automated Cell Culture Systems Market will exhibit a strong CAGR of 8% from 2020-2030. Escalating incidences of chronic ailments have spurred greater research in cytology and cell biology for developing advanced diagnosis and treatment. This is largely an end-product of boundaries in conventional pharmaceuticals. Furthermore, growing complexities of the nature of …
Automated Cell Culture Systems Market expected at a CAGR of ~ 8% & US$ 11 Bn during the forecast period 2020–2030
As per FMI – an ESOMAR-certified market research firm, the automated cell culture systems market will showcase a CAGR of 8% over the forecast period, 2020-2030. High-throughput screening technology has turned out to be the need of the hour, especially with large number of biological/chemical compounds being tested to target a particular ailment. As such, leveraging automation …